95-12398. Delegations of Authority and Organization  

  • [Federal Register Volume 60, Number 97 (Friday, May 19, 1995)]
    [Rules and Regulations]
    [Pages 26825-26826]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-12398]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 5
    
    
    Delegations of Authority and Organization
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the 
    regulations for delegations of authority covering the certification of 
    true documents and use of the Department seal in order to update this 
    authority to reflect recent changes to organizational structures within 
    FDA.
    EFFECTIVE DATE: May 19, 1995.
    
    FOR FURTHER INFORMATION CONTACT: L'Tonya Barnes, Division of Management 
    Systems and Policy (HFA-340), Food and Drug Administration, 5600 
    Fishers Lane, Rockville, MD 20857, 301-443-4976.
    
    SUPPLEMENTARY INFORMATION: FDA is amending the regulations in Sec. 5.22 
    Certification of true copies and use of Department seal (21 CFR 5.22) 
    in order to update this authority to reflect recent changes to 
    organizational structures within FDA. Revisions and deletions have been 
    made to reflect current titles. Also, the following additions have been 
    made to bring the list of officials up-to-date: the Deputy 
    Commissioners; the Director, Division of Management Operations, and 
    Chief, Administrative Management Branch, Office of Resource Management, 
    Office of Regulatory Affairs (ORA); the Director, FDA History Staff, 
    ORA; the Director, Office of Policy, Planning, and Strategic 
    Initiatives, Center for Food Safety and Applied Nutrition (CFSAN); the 
    Director, Office of Management Systems, CFSAN; the Director, Office of 
    Cosmetics and Colors, CFSAN; the Director, Office of Plant and Dairy 
    Foods and Beverages, CFSAN; the Director, Office of Seafood, CFSAN; the 
    Director, Office of Special Nutritionals, CFSAN; the Director, Office 
    of Special Research Skills, CFSAN; the Director, Office of Constituent 
    Operations, CFSAN; the Director, Office of Field Programs, CFSAN; the 
    Director, Office of Premarket Approval, CFSAN; the Director, Office of 
    Scientific Analysis and Support, CFSAN; and the Director, National 
    Forensic Chemistry Center.
        Further redelegation of the authority delegated is not authorized 
    at this time. Authority delegated to a position by title may be 
    exercised by a person officially [[Page 26826]] designated to serve in 
    such position in an acting capacity or on a temporary basis.
    
    List of Subjects in 21 CFR Part 5
    
         Authority delegations (Government agencies), Imports, Organization 
    and functions (Government agencies).
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
    5 is amended as follows:
    
    PART 5--DELEGATIONS OF AUTHORITY AND ORGANIZATION
    
        1. The authority citation for 21 CFR part 5 continues to read as 
    follows:
    
        Authority: 5 U.S.C. 504, 552, App. 2; 7 U.S.C. 138a, 2271; 15 
    U.S.C. 638, 1261-1282, 3701-3711a; secs. 2-12 of the Fair Packaging 
    and Labeling Act (15 U.S.C. 1451-1461); 21 U.S.C. 41-50, 61-63, 141-
    149, 467f, 679(b), 801-886, 1031-1309; secs. 201-903 of the Federal 
    Food, Drug, and Cosmetic Act (21 U.S.C. 321-394); 35 U.S.C. 156; 
    secs. 301, 302, 303, 307, 310, 311, 351, 352, 354, 361, 362, 1701-
    1706; 2101, 2125, 2127, 2128 of the Public Health Service Act (42 
    U.S.C. 241, 242, 242a, 242l, 242n, 243, 262, 263, 263b, 264, 265, 
    300u-300u-5, 300aa-1, 300aa-25, 300aa-27, 300aa-28); 42 U.S.C. 
    1395y, 3246b, 4332, 4831(a), 10007-10008; E.O. 11490, 11921, and 
    12591; secs. 312, 313, 314 of the National Childhood Vaccine Injury 
    Act of 1986, Pub. L. 99-660 (42 U.S.C. 300aa-1 note).
    
        2. Section 5.22 is amended by revising paragraphs (a)(1) through 
    (a)(13) and by adding new paragraph (a)(14), by revising paragraphs 
    (b)(1) and (b)(2), and by adding new paragraph (b)(3) to read as 
    follows:
    
    
    Sec. 5.22  Certification of true copies and use of Department seal.
    
        (a) * * *
        (1) The Deputy Commissioners.
        (2) The Associate and Deputy Associate Commissioners.
        (3)(i) The Director, Office of Executive Operations.
        (ii) The Director, Executive Secretariat.
        (iii) The Director, Program Management Staff.
        (4) The Executive Assistant to the Commissioner, Office of the 
    Commissioner.
        (5)(i) The Director and Deputy Director, Office of Enforcement, 
    Office of Regulatory Affairs (ORA).
        (ii) The Director and Deputy Director, Office of Regional 
    Operations, ORA.
        (iii) The Director and Deputy Director, Office of Resource 
    Management, ORA.
        (iv) The Director, Division of Management Operations, and Chief, 
    Administrative Management Branch, Office of Resource Management, ORA.
        (v) The Director, FDA History Staff, ORA.
        (6)(i) The Director, Division of Management Systems and Policy, 
    Office of Management (OM).
        (ii) The Chief, Dockets Management Branch, Division of Management 
    Systems and Policy, OM.
        (7) The Director, Freedom of Information Staff, Office of Public 
    Affairs.
        (8)(i) The Director and Deputy Directors, Center for Biologics 
    Evaluation and Research (CBER).
        (ii) The Director, Office of Management, CBER.
        (iii) The Directors and Deputy Directors of the Office of 
    Compliance, CBER.
        (iv) The Director of Congressional and Public Affairs Staff, Office 
    of the Center Director, CBER.
        (v) The Chief, Surveillance and Policy Branch and Consumer Safety 
    Officers, Office of Compliance, CBER.
        (9)(i) The Director and Deputy Directors, Center for Food Safety 
    and Applied Nutrition (CFSAN).
        (ii) The Director, Office of Policy, Planning, and Strategic 
    Initiatives, CFSAN.
        (iii) The Director, Office of Management Systems, CFSAN.
        (iv) The Director, Office of Cosmetics and Colors, CFSAN.
        (v) The Director, Office of Plant and Dairy Foods Beverages, CFSAN.
        (vi) The Director, Office of Seafood, CFSAN.
        (vii) The Director, Office of Special Nutritional, CFSAN.
        (viii) The Director, Office of Special Research Skills, CFSAN.
        (ix) The Director, Office of Constituent Operations, CFSAN.
        (x) The Director, Office of Field Programs, CFSAN.
        (xi) The Director, Office of Premarket Approval, CFSAN.
        (xii) The Director, Office of Scientific Analysis and Support, 
    CFSAN.
        (10)(i) The Director and Deputy Director, Center for Devices and 
    Radiological Health (CDRH).
        (ii) The Director, Office of Management Services, CDRH.
        (iii) The Director and Deputy Director, Office of Compliance, CDRH.
        (iv) The Director and Deputy Director, Division of Compliance 
    Programs, CDRH.
        (v) The Director and Deputy Director, Office of Standards and 
    Regulations, CDRH.
        (11)(i) The Director and Deputy Directors, Center for Veterinary 
    Medicine (CVM).
        (ii) The Director and Deputy Director, Office of Management, CVM.
        (iii) The Director and Deputy Director, Office of Surveillance and 
    Compliance, CVM.
        (iv) The Director, Division of Compliance, Office of Surveillance 
    and Compliance, CVM.
        (v) The Chief, Case Guidance Branch, Division of Compliance, Office 
    of Surveillance and Compliance, CVM.
        (12)(i) The Director and Deputy Director, National Center for 
    Toxicological Research (NCTR).
        (ii) The Director, Office of Research Support, NCTR.
        (13)(i) The Director and Deputy Director, Center for Drug 
    Evaluation and Research (CDER).
        (ii) The Directors and Deputy Directors of the Offices of 
    Management, Epidemiology and Biostatistics, Compliance, Drug Evaluation 
    I, Drug Evaluation II, Research Resources, Generic Drugs, and Over-the-
    Counter Drug Evaluation, CDER.
        (iii) The Chief and Freedom of Information Officers, Freedom of 
    Information Staff, Office of Management, CDER.
        (iv) The Director, Division of Management and Budget, Office of 
    Management, CDER.
        (v) The Directors of the Divisions of Drug Labeling Compliance, 
    Drug Quality Evaluation, Manufacturing and Product Quality, and 
    Scientific Investigations, Office of Compliance, CDER.
        (14)(i) Regional Food and Drug Directors.
        (ii) District Directors.
        (iii) The Director, St. Louis Branch.
        (iv) The Director, New York Laboratory Division, Northeast Region.
        (v) The Director, Southeast Regional Laboratory, Southeast Region.
        (vi) The Director, National Forensic Chemistry Center.
        (b) * * *
        (1) Deputy Commissioners.
        (2) The Associate and Deputy Associate Commissioners.
        (3) The Director, Office of Human Resources Management, Office of 
    Management.
    * * * * *
    
        Dated: May 9, 1995.
    William B. Schultz,
    Deputy Commissioner for Policy.
    [FR Doc. 95-12398 Filed 5-18-95; 8:45 am]
    BILLING CODE 4160-01-F
    
    

Document Information

Effective Date:
5/19/1995
Published:
05/19/1995
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
95-12398
Dates:
May 19, 1995.
Pages:
26825-26826 (2 pages)
PDF File:
95-12398.pdf
CFR: (1)
21 CFR 5.22